Eli Lilly and (LLY) had the highest return between 2022 and 2023 by a mega-cap US stock, returning 117.4%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | 2022-2023 | 117.43% |
Novo Nordisk A-S (NVO) | 2022-2023 | 93.94% |
Broadcom (AVGO) | 2022-2023 | 76.83% |
Exxon Mobil (XOM) | 2022-2023 | 75.58% |
NVIDIA (NVDA) | 2022-2023 | 66.33% |
Shell PLC ADR (SHEL) | 2022-2023 | 61.11% |
Merck (MRK) | 2022-2023 | 51.05% |
T-Mobile US (TMUS) | 2022-2023 | 39.11% |
Chevron (CVX) | 2022-2023 | 36.78% |
International Business Machines (IBM) | 2022-2023 | 34.4% |
Novartis AG ADR (NVS) | 2022-2023 | 33.14% |
Oracle (ORCL) | 2022-2023 | 24.69% |
AbbVie (ABBV) | 2022-2023 | 23.71% |
LIN TV (LIN) | 2022-2023 | 22.05% |
Visa Inc Class A (V) | 2022-2023 | 21.55% |
Costco Wholesale (COST) | 2022-2023 | 21.19% |
AstraZeneca PLC ADR (AZN) | 2022-2023 | 20.83% |
Berkshire Hathaway (BRK.A) | 2022-2023 | 20.05% |
Mastercard (MA) | 2022-2023 | 19.97% |
Berkshire Hathaway (BRK.B) | 2022-2023 | 18.85% |
American Express (AXP) | 2022-2023 | 17.06% |
SAP SE ADR (SAP) | 2022-2023 | 15.29% |
McDonald’s (MCD) | 2022-2023 | 15.04% |
Microsoft (MSFT) | 2022-2023 | 14.19% |
JPMorgan Chase (JPM) | 2022-2023 | 13.04% |
Mega-cap stocks are treated as having a market cap of $200B+.
